Therefore, loss of tumor-suppressor genes, notably CDKN2A/B, nullifies the tumor-suppressive activity of IDH mutation, resulting in progression to aggressive IDH-wildtype-like glioma (Figure 2). This evidence concerns the gene CDKN2A and neoplasm.